• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema. 
    •   QMRO Home
    • Institute of Dentistry
    • Centre for Oral Immunobiology and Regenerative Medicine
    • The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
    •   QMRO Home
    • Institute of Dentistry
    • Centre for Oral Immunobiology and Regenerative Medicine
    • The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.

    View/Open
    Accepted version (9.887Mb)
    Volume
    26
    Pagination
    795 - 797
    DOI
    10.1080/09273948.2016.1269931
    Journal
    Ocul Immunol Inflamm
    Issue
    5
    Metadata
    Show full item record
    Abstract
    The use of topical non-steroidal anti-inflammatory drugs in the management of uveitic cystoid macular edema is controversial. In this letter, we review the literature and report our results from a retrospective case series of 281 patients taking topical nepafenac 0.1% for uveitic cystoid macular edema between 2010 and 2016. Over a 4-month period, there was a modest improvement in best-corrected visual acuity (0.66 ± 3.7 logMAR) and central macular thickness (69.8 ± 132.5 μm). Patients with idiopathic anterior uveitis and HLA-B*27-associated anterior uveitis recovered more vision while taking topical nepafenac 0.1%, than those with other uveitides, however, this was not statistically significant. There is a need for controlled prospective studies to evaluate the efficacy of topical non-steroidal anti-inflammatory drugs in the management of uveitic cystoid macular edema. At present, clinicians have little evidence on which to base practice.
    Authors
    Petrushkin, H; Rogers, D; Pavesio, C
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/19440
    Collections
    • Centre for Oral Immunobiology and Regenerative Medicine [465]
    Language
    eng
    Licence information
    This is an Accepted Manuscript of an article published by Taylor & Francis in Ocular Immunology and Inflammation on 12 Jan 2017, available online: http://www.tandfonline.com/10.1080/09273948.2016.1269931.
    Copyright statements
    © 2017 Informa UK Limited.
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.